Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 2
2004 8
2005 3
2006 1
2007 6
2008 6
2009 4
2010 3
2011 4
2012 1
2014 1
2015 1
2017 2
2018 2
2019 2
2020 4
2021 2
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
CD26/DPP-4 in Chronic Myeloid Leukemia.
Sicuranza A, Raspadori D, Bocchia M. Sicuranza A, et al. Among authors: raspadori d. Cancers (Basel). 2022 Feb 11;14(4):891. doi: 10.3390/cancers14040891. Cancers (Basel). 2022. PMID: 35205639 Free PMC article. Review.
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients.
Gozzetti A, Bacchiarri F, Sammartano V, Defina M, Sicuranza A, Mecacci B, Zappone E, Cencini E, Fabbri A, Raspadori D, Bocchia M. Gozzetti A, et al. Among authors: raspadori d. Front Oncol. 2020 Dec 21;10:570187. doi: 10.3389/fonc.2020.570187. eCollection 2020. Front Oncol. 2020. PMID: 33415072 Free PMC article.
Anti CD38 monoclonal antibodies for multiple myeloma treatment.
Gozzetti A, Ciofini S, Simoncelli M, Santoni A, Pacelli P, Raspadori D, Bocchia M. Gozzetti A, et al. Among authors: raspadori d. Hum Vaccin Immunother. 2022 Nov 30;18(5):2052658. doi: 10.1080/21645515.2022.2052658. Epub 2022 Apr 11. Hum Vaccin Immunother. 2022. PMID: 35404740 Free PMC article. Review.
Drug resistance and minimal residual disease in multiple myeloma.
Gozzetti A, Ciofini S, Sicuranza A, Pacelli P, Raspadori D, Cencini E, Tocci D, Bocchia M. Gozzetti A, et al. Among authors: raspadori d. Cancer Drug Resist. 2022 Feb 16;5(1):171-183. doi: 10.20517/cdr.2021.116. eCollection 2022. Cancer Drug Resist. 2022. PMID: 35582527 Free PMC article. Review.
55 results